Skip to content
KalVista Pharmaceuticals, Inc. (KALV) Stock Price, Key Stats & Insider Trading
Home / Companies / KALV KAL
KalVista Pharmaceuticals, Inc. (KALV)
Latest KALV Insider Trades
About KalVista Pharmaceuticals, Inc. (KALV) The SEC lists KalVista Pharmaceuticals, Inc. under CIK 0001348911, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
SEC filings for KALV on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Derivative transaction 77 4,283,873
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
KALV Insider Transactions (Form 4) 75 89 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 3 of 3.
Date Insider Transaction Security Shares Price Value Oct 1, 2025 BS Bethany Sensenig Grant or award Stock Option (right to buy) 45,000
Recent KALV Form 8-K Filings 3 Jun 11, 2026 Item 1.01, 1.02, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 9.01
Read the filing on SEC EDGAR
Recent KALV Form 144 Notices of Proposed Sale 1 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice May 27, 2026 - - - - View on EDGAR
KALV Insider Trading - FAQ
What is the latest insider trade for KALV? KalVista Pharmaceuticals, Inc. (KALV) had 13 insider filings in the last 90 days, with the most recent on 2026-06-11. The full record for KALV runs to 89 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying KALV stock? No insider purchases of KALV were filed in the last 90 days.
How many insiders are selling KALV stock? No insider sales of KALV were filed in the last 90 days. 60 sales are on record for this company.
Where can I see KALV SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks KALV Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow KALV insider buys? Create a free InsiderAlpha account and press Watch on this page to add KALV to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track KALV insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free Open-market sale
$53K
Market cap -
P/E ratio -
Dividend yield -
Average volume 3.42M
52 week high $27.00
52 week low $10.41
Today's high -
Today's low -
Open -
Volume -
Previous close -
Shares outstanding -
Most-Active KALV Insiders - Last 90 Days 10 Oct 1, 2025 PT Patrick Treanor Grant or award Stock Option (right to buy) 30,000 $0.00 -
Oct 1, 2025 NS Nancy Stuart Grant or award Stock Option (right to buy) 30,000 $0.00 -
Aug 22, 2025 NS Nicole Sweeny - Officer Option exercise Common Stock 5,000 - -
Aug 25, 2025 NS Nicole Sweeny - Officer Open-market sale Common Stock 1,480 $13.42 $20K
Aug 22, 2025 NS Nicole Sweeny - Officer Option exercise Restricted Stock Unit 5,000 $0.00 -
Aug 22, 2025 PA Paul K. Audhya - Officer Option exercise Common Stock 5,000 - -
Aug 25, 2025 PA Paul K. Audhya - Officer Open-market sale Common Stock 2,336 $13.42 $31K
Aug 22, 2025 PA Paul K. Audhya - Officer Option exercise Restricted Stock Unit 5,000 $0.00 -
Aug 25, 2025 CY Christopher Yea - Officer Open-market sale Common Stock 1,954 $13.42 $26K
Aug 22, 2025 CY Christopher Yea - Officer Option exercise Restricted Stock Unit 3,125 $0.00 -
Aug 22, 2025 CY Christopher Yea - Officer Open-market sale Common Stock 2,362 $13.22 $31K
Aug 21, 2025 CY Christopher Yea - Officer Option exercise Restricted Stock Unit 3,750 $0.00 -
Aug 21, 2025 PA Paul K. Audhya - Officer Option exercise Common Stock 6,250 - -
Aug 22, 2025 PA Paul K. Audhya - Officer Open-market sale Common Stock 2,942 $13.22 $39K
Aug 21, 2025 PA Paul K. Audhya - Officer Option exercise Restricted Stock Unit 6,250 $0.00 -
Aug 21, 2025 NS Nicole Sweeny - Officer Option exercise Common Stock 6,250 - -
Aug 22, 2025 NS Nicole Sweeny - Officer Open-market sale Common Stock 1,864 $13.22 $25K
Aug 21, 2025 NS Nicole Sweeny - Officer Option exercise Restricted Stock Unit 6,250 $0.00 -
Aug 17, 2025 PA Paul K. Audhya - Officer Option exercise Common Stock 6,446 - -
Aug 18, 2025 PA Paul K. Audhya - Officer Open-market sale Common Stock 2,939 $13.19 $39K
Aug 17, 2025 PA Paul K. Audhya - Officer Option exercise Restricted Stock Unit 2,418 $0.00 -
Aug 17, 2025 PA Paul K. Audhya - Officer Option exercise Restricted Stock Unit 4,028 $0.00 -
Aug 18, 2025 CY Christopher Yea - Officer Open-market sale Common Stock 2,649 $13.19 $35K
Aug 17, 2025 CY Christopher Yea - Officer Option exercise Restricted Stock Unit 1,773 $0.00 -
Aug 17, 2025 CY Christopher Yea - Officer Option exercise Restricted Stock Unit 2,430 $0.00 -
Jul 9, 2025 CY Christopher Yea - Officer Open-market sale Common Stock 30,250 $15.69 $475K
Nov 22, 2024 PA Paul K. Audhya - Officer Option exercise Common Stock 5,000 - -
Nov 26, 2024 PA Paul K. Audhya - Officer Open-market sale Common Stock 2,187 $9.87 $22K
Nov 22, 2024 PA Paul K. Audhya - Officer Option exercise Restricted Stock Unit 5,000 $0.00 -
Nov 26, 2024 CY Christopher Yea - Officer Open-market sale Common Stock 1,963 $9.87 $19K
Nov 22, 2024 CY Christopher Yea - Officer Option exercise Restricted Stock Unit 3,125 $0.00 -
Nov 23, 2024 LR Laurence Reid Grant or award Stock Option (Right to Buy) 17,000 $0.00 -
Nov 18, 2024 CY Christopher Yea - Officer Open-market sale Common Stock 7,192 $9.26 $67K
Nov 17, 2024 CY Christopher Yea - Officer Option exercise Restricted Stock Unit 1,774 $0.00 -
Nov 17, 2024 CY Christopher Yea - Officer Option exercise Restricted Stock Unit 2,431 $0.00 -
Nov 17, 2024 CY Christopher Yea - Officer Option exercise Performance Stock Units 7,291 $0.00 -
Nov 17, 2024 PA Paul K. Audhya - Officer Option exercise Common Stock 18,531 - -
Nov 18, 2024 PA Paul K. Audhya - Officer Open-market sale Common Stock 8,077 $9.26 $75K
Nov 17, 2024 PA Paul K. Audhya - Officer Option exercise Restricted Stock Unit 2,419 $0.00 -
Nov 17, 2024 PA Paul K. Audhya - Officer Option exercise Restricted Stock Unit 4,028 $0.00 -
Nov 17, 2024 PA Paul K. Audhya - Officer Option exercise Performance Stock Units 12,084 $0.00 -
Oct 3, 2024 PT Patrick Treanor Grant or award Stock Option (Right to Buy) 10,000 $0.00 -
Oct 3, 2024 NS Nancy Stuart Grant or award Stock Option (Right to Buy) 10,000 $0.00 -
Oct 3, 2024 WF William Fairey Grant or award Stock Option (Right to Buy) 10,000 $0.00 -
Oct 3, 2024 EU Edward W. Unkart Grant or award Stock Option (Right to Buy) 10,000 $0.00 -
Oct 3, 2024 BP Brian Jg Pereira Grant or award Stock Option (Right to Buy) 10,000 $0.00 -
KPR $CORT
CORCEPT THERAPEUTICS INC
Christopher Yea - OfficerOpen-market sale$905K
Bethany Sensenig
